Loading stock data...

Prism Medico and Pharmacy Limited

BSE: PRISMMEDI

BSE
21.43 1.02 (5.00%)

Prev Close

20.41

Open Price

20.82

Volume

16,686

Today Low / High

20.82 / 21.43

52 WK Low / High

11.62 / 25.79

Range

20 - 23

The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 21.43, reflecting a change of 1.02 (4.99755%). The expected target range on the BSE is 20 - 23. The stock is showing an upward trend on the BSE, making it an appealing option for investors looking for growth in their portfolio.

29 Sep 20.82 2.93%
26 Sep 20.25 0.79%
25 Sep 18.90 2.91%
24 Sep 17.97 3.12%
23 Sep 18.49 -3.24%
22 Sep 17.57 1.82%
19 Sep 17.74 -3.33%
18 Sep 16.83 1.01%
17 Sep 17.42 -1.26%
16 Sep 17.20 1.28%
15 Sep 17.31 -0.87%
12 Sep 16.57 4.47%
11 Sep 16.10 2.42%
10 Sep 15.65 2.88%
09 Sep 17.39 -5.41%
08 Sep 17.38 -0.40%
05 Sep 18.21 -4.56%
04 Sep 17.34 2.94%
03 Sep 16.36 4.95%
02 Sep 16.81 -2.68%

Prism Medico and Pharmacy Limited Graph

Prism Medico and Pharmacy Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for Prism Medico and Pharmacy Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 21.43, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 21.43 21.64 19.48 - 23.81
21.86 17.49 - 26.23
22.07 15.45 - 28.69
Bearish Scenario 21.43 21.22 19.09 - 23.34
21.00 16.80 - 25.20
20.79 14.55 - 27.02

Overview of Prism Medico and Pharmacy Limited

ISIN

INE730E01016

Industry

Financial - Conglomerates

Vol.Avg

11,957

Market Cap

129,939,262

Last Dividend

0

Official Website

Visit Website

IPO Date

2004-08-20

DCF Diff

20.48

DCF

1

Financial Ratios Every Investor Needs

Stock Rating Details for PRISMMEDI

Metric Value Recommendation
Overall Rating C- Strong Sell
DCF Score 3 Neutral
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 2 Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 0.63 Cr 0.45 Cr 0.14 Cr 0.2162 0.00 Cr 0.22 Cr -0.08 Cr -0.05 Cr -0.08 -0.06 Cr -0.0771
2024-03-31 2.93 Cr 2.56 Cr 0.36 Cr 0.1246 0.00 Cr 0.45 Cr -0.09 Cr -0.02 Cr -0.04 -0.08 Cr -0.0073
2023-03-31 1.27 Cr 1.14 Cr 0.13 Cr 0.1022 0.00 Cr 0.10 Cr -0.10 Cr -0.08 Cr -0.13 -0.10 Cr -0.0601
2022-03-31 8.44 Cr 8.63 Cr -0.18 Cr -0.0218 0.00 Cr 0.02 Cr -0.50 Cr -0.37 Cr -0.61 -0.49 Cr -0.0438
2021-03-31 16.76 Cr 16.67 Cr 0.10 Cr 0.0057 0.00 Cr 0.07 Cr -0.17 Cr -0.13 Cr -0.21 -0.16 Cr -0.0078

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 0.07 Cr 15.56 Cr 0.47 Cr 15.0928 Cr 0.00 Cr -0.07 Cr 6.77 Cr 0.03 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.4716 Cr
2024-03-31 0.08 Cr 15.24 Cr 0.10 Cr 15.1415 Cr 0.00 Cr -0.08 Cr 6.77 Cr 0.03 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.1015 Cr
2023-03-31 0.10 Cr 15.39 Cr 0.23 Cr 15.1615 Cr 0.00 Cr -0.10 Cr 6.77 Cr 0.03 Cr 0.03 Cr 0.00 Cr 0.00 Cr 0.2317 Cr
2022-03-31 0.06 Cr 12.57 Cr 0.02 Cr 12.5548 Cr 0.00 Cr -0.06 Cr 6.77 Cr 0.05 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.0174 Cr
2021-03-31 0.08 Cr 21.54 Cr 8.62 Cr 12.9259 Cr 0.00 Cr -0.08 Cr 4.85 Cr 0.06 Cr 0.00 Cr 0.00 Cr 1.94 Cr 8.6161 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 -0.0165 Cr 0.0000 Cr -0.0017 Cr -0.0165 Cr -0.0182 Cr 0.0654 Cr 0.0000 Cr -0.0487 Cr 0.0000 Cr 0.0000 Cr 0.0000 Cr
2024-03-31 -0.0050 Cr 0.0000 Cr -0.0071 Cr -0.0050 Cr -0.0121 Cr 0.0836 Cr 0.0000 Cr -0.0280 Cr 0.0000 Cr 0.0000 Cr 0.0000 Cr
2023-03-31 2.9543 Cr -2.9133 Cr -0.0003 Cr 2.9543 Cr 0.0406 Cr 0.0957 Cr 0.0000 Cr -0.1022 Cr 0.0000 Cr 0.0000 Cr 0.0000 Cr
2022-03-31 -2.3790 Cr 2.3504 Cr -0.0005 Cr -2.3790 Cr -0.0290 Cr 0.0551 Cr 0.0000 Cr -0.4989 Cr 0.0000 Cr 0.0000 Cr -1.9240 Cr
2021-03-31 -0.0515 Cr 0.0241 Cr -0.0002 Cr -0.0515 Cr -0.0276 Cr 0.0841 Cr 0.0000 Cr -0.1752 Cr 0.0000 Cr 0.0000 Cr -4.7991 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-06-30 1.59 Cr 0.86 Cr 0.73 Cr 0.4603 0.65 Cr 0.66 Cr 0.01 0.65 Cr 0.4137
2025-03-31 0.07 Cr 0.01 Cr 0.06 Cr 0.8420 0.01 Cr 0.04 Cr 0.07 0.02 Cr 0.5701
2024-12-31 0.21 Cr 0.15 Cr 0.06 Cr 0.2704 -0.01 Cr -0.01 Cr -0.02 -0.01 Cr -0.0460
2024-09-30 0.29 Cr 0.24 Cr 0.05 Cr 0.1772 0.01 Cr 0.01 Cr 0.02 0.01 Cr 0.0327
2024-06-30 0.06 Cr 0.06 Cr 0.00 Cr 0.0542 -0.09 Cr -0.09 Cr -0.15 -0.09 Cr -1.4354

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-03-31 0.07 Cr 0.00 Cr 0.07 Cr 7.10 Cr 6.77 Cr 15.30 Cr 0.03 Cr 15.56 Cr 0.47 Cr
2024-09-30 0.08 Cr 0.00 Cr 0.08 Cr 7.33 Cr 6.77 Cr 14.91 Cr 0.03 Cr 15.16 Cr 0.10 Cr
2024-06-30 0.00 Cr 0.00 Cr 0.08 Cr 0.00 Cr 0.00 Cr 0.08 Cr 0.00 Cr 0.00 Cr -15.14 Cr
2024-03-31 0.08 Cr 0.00 Cr 0.08 Cr 3.69 Cr 6.77 Cr 14.99 Cr 0.03 Cr 15.24 Cr 0.10 Cr
2023-12-31 -0.08 Cr 0.16 Cr 0.08 Cr 0.00 Cr 0.00 Cr 0.08 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2024-09-30 0.01 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 -0.09 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-03-31 -0.07 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-12-31 0.19 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2023-09-30 -0.05 Cr 0.47 Cr -0.48 Cr 0.00 Cr -0.05 Cr -0.05 Cr 0.00 Cr 0.00 Cr 0.47 Cr

Splits History

Date Label Split Ratio
No split history data available.

Similar Stocks: Financial - Conglomerates

Company Name Symbol Price Market Cap Volume
Bajaj Finserv Ltd. BAJAJFINSV ₹2,024.70 ₹3,231,920,950,627.00 ₹2,004,975.00
Aditya Birla Capital Limited ABCAPITAL ₹289.85 ₹757,215,734,000.00 ₹8,152,878.00
IndiGrid Infrastructure Trust INDIGRID-IV ₹167.45 ₹139,746,737,100.00 ₹374,472.00

Key Executives

Whole Time Director
Ms. Sakshi Laller

Gender: female

Year Born:

Chief Financial Officer
Mr. Bharat Singh

Gender: male

Year Born:

Company Secretary & Compliance Officer
Mr. Sameer Gupta

Gender: male

Year Born:

FAQs about Prism Medico and Pharmacy Limited

Who is the CEO of the company?

The CEO is Sakshi Laller.

What is the current market price of the stock?

The current price is ₹21.43.

What is the 52-week price range?

The range is ₹11.62-25.79.

What is the market capitalization of the company?

The market capitalization is ₹12.99 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 18.60.

Which sector does the company belong to?

The company operates in the Financial Services sector.

What does the company do?

Overview of Prism Medico and Pharmacy Limited (ISIN: INE730E01016) is a leading Financial - Conglomerates in India. With a market capitalization of ₹12.99 crores and an average daily volume of 11,957 shares, it operates in the Financial - Conglomerates. The company last declared a dividend of ₹0.